Molecular diagnostics in severe pneumonia: a new dawn or false promise?
Intensive Care Med
.
2022 Jun;48(6):740-742.
doi: 10.1007/s00134-022-06722-0.
Epub 2022 May 13.
Authors
Andrew Conway Morris
1
2
3
,
Lieuwe D J Bos
4
,
Saad Nseir
5
6
Affiliations
1
Division of Immunology, Department of Pathology, University of Cambridge, Cambridge, UK.
2
Division of Anaesthesia, Department of Medicine, University of Cambridge, Cambridge, UK.
3
JVF Intensive Care Unit, Addenbrooke's Hospital, Cambridge, UK.
4
Intensive Care, Amsterdam UMC-Location AMC, University of Amsterdam, Amsterdam, The Netherlands.
5
Médecine Intensive-Réanimation, Hôpital R. Salengro, CHU de Lille, 59000, Lille, France. s-nseir@chru-lille.fr.
6
Inserm U1285, Université de Lille, CNRS, UMR 8576-UGSF, 59000, Lille, France. s-nseir@chru-lille.fr.
PMID:
35552790
DOI:
10.1007/s00134-022-06722-0
No abstract available
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
Humans
Pathology, Molecular*
Pneumonia* / diagnosis
Grants and funding
MR/V006118/1/MRC_/Medical Research Council/United Kingdom